SNP rs2240688 in CD133 gene on susceptibility and clinicopathological features of hepatocellular carcinoma

Pan, Xiaolan; Huang, Liuliu; Mo, Dan; Liang, Yucheng; Huang, Zhaodong; Zhu, Bo; Fang, Min

doi:10.21037/tcr-19-2690

Cited by 2 publications

(1 citation statement)

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pathological grading of HCC is an important predictor of the recurrence and survival of HCC patients after surgery or liver transplantation ( 6 , 7 ). The risk of recurrence and metastasis of patients with poorly-differentiated HCC is significantly higher than that of patients with moderately-differentiated HCC ( 14 , 15 ). Accurately assessing the differentiation degree of HCC before treatment can help clinicians formulate and adjust treatment plans, and it is also beneficial for assessing the efficacy and prognosis after treatment.…”

Section: Discussionmentioning

confidence: 93%

Application of contrast-enhanced ultrasound in the pathological grading and prognosis prediction of hepatocellular carcinoma

Xuan¹,

Wu²,

Li³

et al. 2021

Transl Cancer Res TCR

View full text Add to dashboard Cite

Background: To explore the clinical application value of contrast-enhanced ultrasound (CEUS) in the pathological grading and prognosis prediction of hepatocellular carcinoma (HCC).Methods: A retrospective analysis was performed of 128 patients with primary HCC who underwent CEUS examination in our hospital from January 2017 to June 2020. Patients were divided into three groups: highly-differentiated group, moderately-differentiated group, and poorly-differentiated group. Quantitative analysis of the relationships between the rise time (RT), time to peak (TTP), mean transit time (mTT), intensity maximum (Imax), enhancement rate, and pathological grade of CEUS was performed. In addition, the follow-up patients were divided into a recurrence group and non-recurrence group, and the relationships between RT, TTP, mTT, Imax, and enhancement rate of CEUS were analyzed.Results: Among the 128 patients, 23 were highly-differentiated, 63 were moderately-differentiated, and 42 were poorly-differentiated. In addition, there were 31 patients in the recurrence group and 97 patients in the non-recurrence group. RT, TTP, and enhancement rate had significant differences in the highlydifferentiated, moderately-differentiated, and poorly-differentiated groups. At the same time, RT and TTP were positively correlated with the differentiation degree, while the enhancement rate was negatively correlated with the differentiation degree. Furthermore, RT, TTP, and enhancement rate were statistically significant for the diagnosis of HCC with high, moderate, and poor differentiation, among which RT had the highest diagnostic accuracy. In the recurrence group, RT, TTP, and Imax were lower than those in the nonrecurrence group, and the enhancement rate was greater than that in the non-recurrence group. Moreover, low levels of RT, TTP, and Imax along with positive microvascular invasion (MVI) and poor differentiation were risk factors for HCC recurrence, and there was no significant relationship between the average tumor diameter and HCC recurrence.Conclusions: CEUS can significantly show the differences between the RT, TTP, and enhancement rate of HCC across different levels of differentiation. It can also predict whether the disease will relapse.Moreover, low levels of RT, TTP, and Imax as well as positive MVI and poor differentiation can cause the recurrence of HCC.

show abstract